NEW QIAstat-Dx Respiratory 2019-nCoV Panel 

NEW QIAstat-Dx Respiratory 2019-nCoV Panel 

Molecular Diagnostics

March 03, 2020

To support the research efforts for accessible testing to meet the demands of the COVID-19 outbreak, QIAGEN® developed the QIAstat-Dx® Respiratory 2019-nCoV Panel. This version of our multiplex syndromic cartridge detects and differentiates 22 respiratory targets, including 2019-nCoV (SARS-CoV-2).

  • Includes 2 molecular targets specific to 2019-nCoV: ORF1b gene recommended by the Chinese Center for Disease Control and Prevention, and the E gene recommended by the US Centers for Disease Control and Prevention
  • Less than 1 minute hands-on time
  • Time to result: approximately 1 hour
NEW RIDASCREEN Chloramphenicol

NEW RIDASCREEN Chloramphenicol

Molecular Diagnostics

The new RIDASCREEN Chloramphenicol (R1511)  is a competitive enzyme immunoassay for the quantitative analysis of chloramphenicol in milk, milk powder, dairy products, honey and royal jelly, meat, fish, shrimp, eggs, urine (also chloramphenicol glucuronide), plasma/serum and feed. The test kit contains all reagents required for the enzyme immunoassay.

November 24, 2016 More +
SOMATIC 2 MASTR Plus and QC Plex Product Release

SOMATIC 2 MASTR Plus and QC Plex Product Release

Molecular Diagnostics

Multiplicom is pleased to introduce the SOMATIC 2 MASTR™ Plus, a research use only assay, for sequencing analysis of genes involved in pathways of solid tumors formation. The SOMATIC 2 MASTR Plus is provided as a ready to use assay in three multiplex PCR reactions for the identification of mutations in the complete coding regions of the EGFR, ERBB2, PIK3CA, PIK3R1 and PTEN genes.

March 24, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us